{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:07:11Z","timestamp":1786540031791,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sapharm.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:07:47Z","timestamp":1746792467000},"page":"679-686","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Deprescribing tools and guidelines in chronic kidney disease: A scoping review"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2859-1370","authenticated-orcid":false,"given":"Amani","family":"Zidan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hager","family":"ElGeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Alsalemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9029-8925","authenticated-orcid":false,"given":"Ahmed","family":"Awaisu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2025.05.005_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.sapharm.2025.05.005_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.sapharm.2025.05.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-015-0189-z","article-title":"The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study","volume":"16","author":"Fraser","year":"2015","journal-title":"BMC Nephrol"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.31128\/AJGP-11-20-5752","article-title":"Prescribing and deprescribing in chronic kidney disease. Article","volume":"50","author":"Manski-Nankervis","year":"2021","journal-title":"Aust J Gen Pract."},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.005_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bcp.12959","article-title":"Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta\u2010analysis","volume":"82","author":"Johansson","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.005_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jamda.2019.07.007","article-title":"Polypharmacy and kidney function in community-dwelling adults age 60 years and older: a prospective observational study","volume":"21","author":"Ernst","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.sapharm.2025.05.005_bib8","series-title":"Drug Management in the Elderly Adult with Chronic Kidney Disease: A Review for the Primary Care Physician","first-page":"633","author":"Ponticelli","year":"2015"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib9","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jgs.14662","article-title":"Association of multimorbidity with mortality and healthcare utilization in chronic kidney disease","volume":"65","author":"Bowling","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sapharm.2025.05.005_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","article-title":"Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action","volume":"38","author":"Reeve","year":"2017","journal-title":"Eur J Intern Med"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1715163520929734","article-title":"Evaluating an inpatient deprescribing initiative at a rural community hospital in Ontario","volume":"153","author":"Gazarin","year":"2020","journal-title":"Can Pharm J"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.005_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.ajkd.2017.05.025","article-title":"Deprescribing in CKD: the proof is in the process. Editorial","volume":"70","author":"Whittaker","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.005_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1001\/jama.294.6.716","article-title":"Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance","volume":"294","author":"Boyd","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122246","article-title":"What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process","volume":"10","author":"Farrell","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.sapharm.2025.05.005_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274552","article-title":"Barriers and enablers to deprescribing in long-term care: a qualitative investigation into the opinions of healthcare professionals in Ireland","volume":"17","author":"Heinrich","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.005_bib16","doi-asserted-by":"crossref","DOI":"10.3399\/bjgpopen20X101096","article-title":"Barriers and facilitators to deprescribing in primary care: a systematic review","volume":"4","author":"Doherty","year":"2020","journal-title":"BJGP open"},{"key":"10.1016\/j.sapharm.2025.05.005_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40266-013-0106-8","article-title":"Patient barriers to and enablers of deprescribing: a systematic review","volume":"30","author":"Reeve","year":"2013","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.sapharm.2025.05.005_bib18","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/bcp.13912","article-title":"Availability and readability of patient education materials for deprescribing: an environmental scan","volume":"85","author":"Fajardo","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jppr.1626","article-title":"Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice","volume":"50","author":"Reeve","year":"2020","journal-title":"J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-019-1031-4","article-title":"Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review","volume":"19","author":"Ulley","year":"2019","journal-title":"BMC Geriatr"},{"issue":"11","key":"10.1016\/j.sapharm.2025.05.005_bib21","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","article-title":"Deprescribing for community-dwelling older adults: a systematic review and meta-analysis","volume":"35","author":"Bloomfield","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053112","article-title":"Deprescribing montelukast in children with asthma: a systematic review","volume":"12","author":"Dixon","year":"2022","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.005_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2021-001509","article-title":"Deprescribing for all: a narrative review identifying inappropriate polypharmacy for all ages in hospital settings","volume":"10","author":"Elbeddini","year":"2021","journal-title":"BMJ Open Quality"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.31128\/AJGP-11-20-5752","article-title":"Prescribing and deprescribing in chronic kidney disease","volume":"50","author":"Manski-Nankervis","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.sapharm.2025.05.005_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/ajhp\/zxaf051","article-title":"Deprescribing in chronic kidney disease: an essential component of comprehensive medication management","author":"Battistella","year":"2025","journal-title":"Am J Health Syst Pharm"},{"issue":"11","key":"10.1016\/j.sapharm.2025.05.005_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40266-018-0593-8","article-title":"The role of deprescribing in older adults with chronic kidney disease","volume":"35","author":"Triantafylidis","year":"2018","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1016\/j.sapharm.2025.05.005_bib27","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"7","key":"10.1016\/j.sapharm.2025.05.005_bib28","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.sapharm.2025.05.005_bib29","series-title":"Identification and Characterization of Deprescribing Tools and Guidance for Patients with Chronic Kidney Disease: A Scoping Review","author":"Zidan","year":"2025"},{"issue":"8","key":"10.1016\/j.sapharm.2025.05.005_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jama.2018.9660","article-title":"Clinical practice guidelines: what's next?","volume":"320","author":"Shekelle","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ejhpharm-2015-000864","article-title":"Review of structured guides for deprescribing","volume":"24","author":"Scott","year":"2017","journal-title":"Eur J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.005_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamainternmed.2021.7429","article-title":"The MedSafer study-electronic decision support for deprescribing in hospitalized older adults: a cluster randomized clinical trial. Journal article","volume":"182","author":"McDonald","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.005_bib34","doi-asserted-by":"crossref","first-page":"520","DOI":"10.11124\/JBIES-22-00123","article-title":"Recommendations for the extraction, analysis, and presentation of results in scoping reviews","volume":"21","author":"Pollock","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"18","key":"10.1016\/j.sapharm.2025.05.005_bib35","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"Agree II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"9","key":"10.1016\/j.sapharm.2025.05.005_bib36","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.34067\/KID.0001942021","article-title":"Less is more: deprescribing medications in older adults with kidney disease: a review","volume":"2","author":"Mohottige","year":"2021","journal-title":"Kidney360"},{"issue":"11","key":"10.1016\/j.sapharm.2025.05.005_bib37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/nep.13936","article-title":"Active deprescribing program in chronic kidney disease patients undergoing haemodialysis","volume":"26","author":"George","year":"2021","journal-title":"Nephrology"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.005_bib38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1159\/000363115","article-title":"Cost savings using a protocol approach to manage anemia in a hemodialysis unit","volume":"39","author":"Charlesworth","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.sapharm.2025.05.005_bib39","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1093\/ajhp\/zxac190","article-title":"Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis. Article","volume":"79","author":"Gerardi","year":"2022","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sapharm.2025.05.005_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/2054358120968674","article-title":"Development and validation of nine deprescribing algorithms for patients on hemodialysis to decrease polypharmacy","volume":"7","author":"Lefebvre","year":"2020","journal-title":"Can J Kidney Health Dis"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.005_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/cd21-0078","article-title":"Medication optimization for new initiators of Empagliflozin for diabetic kidney disease","volume":"40","author":"Swanner","year":"2022","journal-title":"Clin Diabetes"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.005_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2017.02.374","article-title":"Targeted deprescribing in an outpatient hemodialysis unit: a quality improvement study to decrease polypharmacy","volume":"70","author":"McIntyre","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.005_bib43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.ajkd.2011.04.020","article-title":"Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD","volume":"58","author":"Desrochers","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.sapharm.2025.05.005_bib44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1590\/2175-8239-jbn-2019-0205","article-title":"Pharmacotherapy assessment in chronic kidney disease: validation of the PAIR instrument for use in Brazil","volume":"42","author":"Marquito","year":"2020","journal-title":"J Bras Nefrol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.005_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40360-024-00754-6","article-title":"Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital","volume":"25","author":"Pehlivanli","year":"2024","journal-title":"BMC Pharmacol Toxicol"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.005_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100810","article-title":"Medication deprescribing in patients receiving hemodialysis: a prospective controlled quality improvement study","volume":"6","author":"Bortolussi-Courval","year":"2024","journal-title":"Kidney Medicine"},{"key":"10.1016\/j.sapharm.2025.05.005_bib47","first-page":"A25","article-title":"The medsafer pilot results: electronic deprescribing for hospitalized older adults with polypharmacy. Journal article; Conference proceeding","volume":"23","author":"McDonald","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.sapharm.2025.05.005_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/20543581221098778","article-title":"Deprescribing opportunities for hospitalized patients with end-stage kidney disease on hemodialysis: a secondary analysis of the MedSafer cluster randomized controlled trial","volume":"9","author":"Moryousef","year":"2022","journal-title":"Can J Kidney Health Dis"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.005_bib49","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sapharm.2025.05.005_bib50","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1176\/appi.ps.201500359","article-title":"A prescription for \"deprescribing\" in psychiatry","volume":"67","author":"Gupta","year":"2016","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.sapharm.2025.05.005_bib51","first-page":"1180","article-title":"Conservatively managed patients with advanced CKD: what medications can be deprescribed? Conference Abstract","volume":"30","author":"Jahan","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.sapharm.2025.05.005_bib52","article-title":"The persistent underrepresentation of patients with chronic kidney disease in cardiovascular trials: a systematic review and evidence map of exclusion and outcomes","volume":"18","author":"Colombijn","year":"2023","journal-title":"medRxiv. Jul"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.005_bib53","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/jgs.16388","article-title":"Cost\u2010effectiveness of pharmacist\u2010led Deprescribing of NSAIDs in community\u2010dwelling older adults","volume":"68","author":"Sanyal","year":"2020","journal-title":"J Am Geriatr Socy"},{"issue":"9","key":"10.1016\/j.sapharm.2025.05.005_bib54","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1016\/j.sapharm.2022.03.008","article-title":"Identification and characterisation of deprescribing tools for older patients: a scoping review","volume":"18","author":"Mej\u00edas-Trueba","year":"2022","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2025.05.005_bib55","first-page":"28","article-title":"What do clinical practice guidelines say about deprescribing? A scoping review","volume":"34","author":"Langford","year":"2025","journal-title":"BMJ Qual Saf"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112500244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112500244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:04:10Z","timestamp":1750179850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112500244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S155174112500244X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.005","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deprescribing tools and guidelines in chronic kidney disease: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}